Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
about
Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failureCardiorespiratory effects of continuous i.v. administration of the ACE inhibitor enalaprilat in the critically ill.Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects.A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failureClinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.Long-term captopril therapy in severe refractory congestive heart failureRegional circulatory response to converting-enzyme inhibition in congestive heart failurePrognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.Isolated circulatory response to intravenous administration of the ACE inhibitor enalaprilat.Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failureHaemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure.Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.The use of angiotensin-converting enzyme inhibitors in congestive heart failure.Clinical response to angiotensin-converting enzyme inhibition in cardiac failure.High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril.Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure.Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters.Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure.Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle.The renal effects of dopamine and dobutamine in stable chronic heart failure.[Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].Disposition of procainamide in patients with chronic congestive heart failure receiving medical therapy.Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects.[Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
P2860
Q28360410-CF1C647A-BEE3-41B7-A175-EBB02A586E07Q34347635-2DDFB069-4E3F-4ABA-9FF9-8521C5FAB56FQ34357597-8769E627-8322-4DCB-8602-7DEDAE4B0756Q34358032-F2D30480-749A-41CA-B52E-E46C8FE4F4D7Q34487124-12868230-3760-4F82-9157-B05E611CF8B7Q34511334-91A65EB4-921C-42C8-BBAB-897810363570Q34511422-276376BA-6B1C-4A12-821A-9EEF7C19C228Q35640412-1CF714D0-1642-44A5-8090-49EBF51A6B34Q36732862-DE506659-3D90-4F9E-AB0E-498909B4C17BQ36750860-11832D48-4AB8-4028-962A-FE52C405145AQ36756934-31A77EC5-347C-47AC-BC53-4D356BCB12B2Q36818647-5FCB8C40-984B-468E-95BE-5E9053195036Q36854757-D1A16E57-AA80-4F98-B939-37D8C6F47326Q37768501-808F3C82-F04B-4A9B-BFC8-19B1ED46FB5BQ38215916-2A58C0F5-571B-4364-A6FB-2D9E7C8702AEQ38215931-1A4C527C-7B87-4A90-B00F-55746CE5A10DQ39510458-48ACD042-37EE-43AE-B5CD-DF0E55EA86E5Q39522679-9CBEFA7B-50CF-4E6C-B7C0-9F90FBDA2E0FQ39612680-18969AEC-04D1-4ACF-8889-D354583F6F8AQ39866837-8DD41FFD-528A-41BC-BEFE-4DDF85C9FF8BQ41760473-8E4A9F92-C5DB-4B62-98EE-9020FBEE7400Q42979461-433CA40C-B1FF-4083-8816-74E7FB2159E7Q43038564-F7A98B42-6162-4186-9668-2075045E7A52Q43240457-68621D14-1E8E-4076-9D29-3C8AE6D6978BQ44383548-9BEF7F9A-A656-4897-97A5-F0D9B28E2AF9Q50990093-D91180C3-C14D-4D61-9302-8AA1B0535410Q51749328-9F6CC465-80DB-4C1B-AA14-26F618908829Q53787311-510E2260-2475-4BD9-8EF1-C790314261D4Q54153341-4DE2448A-3869-45BD-8DF4-5AAE40612DF0Q54277743-ECA0E3EC-AF1C-4FBF-984E-252F8870452EQ54332604-249AC044-7AD3-4B49-9007-C6ED837C7B6BQ54348022-56642549-4F2E-451B-B946-3FCA814CF019
P2860
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Acute regional circulatory and ...... with congestive heart failure.
@en
Acute regional circulatory and ...... with congestive heart failure.
@nl
type
label
Acute regional circulatory and ...... with congestive heart failure.
@en
Acute regional circulatory and ...... with congestive heart failure.
@nl
prefLabel
Acute regional circulatory and ...... with congestive heart failure.
@en
Acute regional circulatory and ...... with congestive heart failure.
@nl
P2093
P356
P1433
P1476
Acute regional circulatory and ...... with congestive heart failure.
@en
P2093
Bernard DB
Creager MA
Halperin JL
Melidossian CD
P304
P356
10.1161/01.CIR.64.3.483
P407
P577
1981-09-01T00:00:00Z